1. Home
  2. SPCB vs CTXR Comparison

SPCB vs CTXR Comparison

Compare SPCB & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPCB
  • CTXR
  • Stock Information
  • Founded
  • SPCB 1988
  • CTXR 2007
  • Country
  • SPCB Israel
  • CTXR United States
  • Employees
  • SPCB N/A
  • CTXR N/A
  • Industry
  • SPCB Semiconductors
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPCB Technology
  • CTXR Health Care
  • Exchange
  • SPCB Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • SPCB 31.4M
  • CTXR 28.4M
  • IPO Year
  • SPCB N/A
  • CTXR N/A
  • Fundamental
  • Price
  • SPCB $10.77
  • CTXR $1.80
  • Analyst Decision
  • SPCB Strong Buy
  • CTXR Strong Buy
  • Analyst Count
  • SPCB 1
  • CTXR 2
  • Target Price
  • SPCB $18.00
  • CTXR $54.50
  • AVG Volume (30 Days)
  • SPCB 407.6K
  • CTXR 183.4K
  • Earning Date
  • SPCB 11-14-2024
  • CTXR 02-14-2025
  • Dividend Yield
  • SPCB N/A
  • CTXR N/A
  • EPS Growth
  • SPCB N/A
  • CTXR N/A
  • EPS
  • SPCB 1.02
  • CTXR N/A
  • Revenue
  • SPCB $26,843,000.00
  • CTXR N/A
  • Revenue This Year
  • SPCB $6.72
  • CTXR N/A
  • Revenue Next Year
  • SPCB $16.91
  • CTXR $216.25
  • P/E Ratio
  • SPCB $11.06
  • CTXR N/A
  • Revenue Growth
  • SPCB 5.23
  • CTXR N/A
  • 52 Week Low
  • SPCB $2.55
  • CTXR $1.47
  • 52 Week High
  • SPCB $18.95
  • CTXR $26.75
  • Technical
  • Relative Strength Index (RSI)
  • SPCB 51.88
  • CTXR 21.53
  • Support Level
  • SPCB $10.50
  • CTXR $1.47
  • Resistance Level
  • SPCB $13.69
  • CTXR $2.97
  • Average True Range (ATR)
  • SPCB 1.25
  • CTXR 0.29
  • MACD
  • SPCB -0.17
  • CTXR -0.05
  • Stochastic Oscillator
  • SPCB 41.25
  • CTXR 22.00

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT and Connectivity, which is the key revenue driver; and Cyber Security. Besides, it also offers a wide range of solutions that include national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management using the common platform. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and the Asia Pacific.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.

Share on Social Networks: